BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37621083)

  • 21. Efficacy of high-vision transnasal endoscopy using texture and colour enhancement imaging and narrow-band imaging to evaluate gastritis: a randomized controlled trial.
    Sugimoto M; Kawai Y; Morino Y; Hamada M; Iwata E; Niikura R; Nagata N; Koyama Y; Fukuzawa M; Itoi T; Kawai T
    Ann Med; 2022 Dec; 54(1):1004-1013. PubMed ID: 35441573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development.
    Hara D; Okamura T; Iwaya Y; Nagaya T; Ota H; Umemura T
    Helicobacter; 2022 Dec; 27(6):e12934. PubMed ID: 36263778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consistency between the endoscopic Kyoto classification and pathological updated Sydney system for gastritis: A cross-sectional study.
    Toyoshima O; Nishizawa T; Yoshida S; Matsuno T; Odawara N; Toyoshima A; Sakitani K; Watanabe H; Fujishiro M; Suzuki H
    J Gastroenterol Hepatol; 2022 Feb; 37(2):291-300. PubMed ID: 34569096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of endoscopic gastritis based on Kyoto classification between diffuse and intestinal gastric cancer.
    Toyoshima O; Nishizawa T; Yoshida S; Aoki T; Nagura F; Sakitani K; Tsuji Y; Nakagawa H; Suzuki H; Koike K
    World J Gastrointest Endosc; 2021 May; 13(5):125-136. PubMed ID: 34046150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
    Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
    Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The corpus-predominant gastritis index may serve as an early marker of Helicobacter pylori-infected patients at risk of gastric cancer.
    Tsai YC; Hsiao WH; Yang HB; Cheng HC; Chang WL; Lu CC; Sheu BS
    Aliment Pharmacol Ther; 2013 May; 37(10):969-78. PubMed ID: 23550594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kyoto classification of gastritis: Advances and future perspectives in endoscopic diagnosis of gastritis.
    Toyoshima O; Nishizawa T
    World J Gastroenterol; 2022 Nov; 28(43):6078-6089. PubMed ID: 36483157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.
    De Re V; Orzes E; Canzonieri V; Maiero S; Fornasarig M; Alessandrini L; Cervo S; Steffan A; Zanette G; Mazzon C; De Paoli P; Cannizzaro R
    Clin Transl Gastroenterol; 2016 Jul; 7(7):e183. PubMed ID: 27441820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staging of operative link on gastritis assessment and operative link on gastric intestinal metaplasia systems for risk assessment of early gastric cancer: a case-control study.
    Huang Y; Chen J; Guo Y; Ding Z; Liang X; Zhang W; Xue H; Zhao Y; Li X; Lu H
    J Clin Pathol; 2023 Nov; ():. PubMed ID: 37989553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity of endoscopic features for the diagnosis of Helicobacter pylori infection status based on the Kyoto classification of gastritis.
    Yoshii S; Mabe K; Watano K; Ohno M; Matsumoto M; Ono S; Kudo T; Nojima M; Kato M; Sakamoto N
    Dig Endosc; 2020 Jan; 32(1):74-83. PubMed ID: 31309632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia.
    Quach DT; Le HM; Hiyama T; Nguyen OT; Nguyen TS; Uemura N
    Helicobacter; 2013 Apr; 18(2):151-7. PubMed ID: 23167960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic grading of gastric intestinal metaplasia on risk assessment for early gastric neoplasia: can we replace histology assessment also in the West?
    Marcos P; Brito-Gonçalves G; Libânio D; Pita I; Castro R; Sá I; Dinis-Ribeiro M; Pimentel-Nunes P
    Gut; 2020 Oct; 69(10):1762-1768. PubMed ID: 32051208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric cancer incidence based on endoscopic Kyoto classification of gastritis.
    Toyoshima O; Nishizawa T; Yoshida S; Matsuno T; Fujisawa G; Toyoshima A; Ebinuma H; Fujishiro M; Saito Y; Suzuki H
    World J Gastroenterol; 2023 Aug; 29(31):4763-4773. PubMed ID: 37664152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of histological gastritis based on the Kyoto classification of gastritis in Japanese subjects - including evaluation of aging and sex difference of histological gastritis.
    Sumi N; Haruma K; Kamada T; Suehiro M; Manabe N; Akiyama T; Shiotani A; Yamanaka Y; Fujimoto S; Takao T
    Scand J Gastroenterol; 2022 Mar; 57(3):260-265. PubMed ID: 34807790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Cyclooxygenase-2 1195 G-Carrier Genotype Associated with Intestinal Metaplasia and Endoscopic Findings Based on Kyoto Classification.
    Kodaka Y; Futagami S; Tatsuguchi A; Yamawaki H; Sato H; Hashimoto S; Kawagoe T; Ueki N; Nagoya H; Maruki Y; Miyake K; Gudis K; Sakamoto C; Iwakiri K
    Digestion; 2017; 96(3):173-183. PubMed ID: 28946145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum pepsinogen levels and OLGA/OLGIM staging in the assessment of atrophic gastritis types.
    Ogutmen Koc D; Bektas S
    Postgrad Med J; 2022 Jun; 98(1160):441-445. PubMed ID: 33380437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linked color imaging identifies important risk factors associated with gastric cancer after successful eradication of Helicobacter pylori.
    Majima A; Dohi O; Takayama S; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Ishikawa T; Takagi T; Handa O; Konishi H; Naito Y; Itoh Y
    Gastrointest Endosc; 2019 Nov; 90(5):763-769. PubMed ID: 31299258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems.
    Cho SJ; Choi IJ; Kook MC; Nam BH; Kim CG; Lee JY; Ryu KW; Kim YW
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1292-302. PubMed ID: 24134499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OLGA- and OLGIM-based staging of gastritis using narrow-band imaging magnifying endoscopy.
    Saka A; Yagi K; Nimura S
    Dig Endosc; 2015 Nov; 27(7):734-41. PubMed ID: 25923666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study.
    Salazar BE; Pérez-Cala T; Gomez-Villegas SI; Cardona-Zapata L; Pazos-Bastidas S; Cardona-Estepa A; Vélez-Gómez DE; Justinico-Castro JA; Bernal-Cobo A; Dávila-Giraldo HA; Benítez-Guerra JC; Valencia-Cárdenas JT; Ospina EJ; Castaño-Llano R; Bravo MM; Cataño-Correa JC; Zabaleta J; Trespalacios-Rangel AA; Cock-Botero AM; Roldán-Pérez MI; Martínez A
    Virchows Arch; 2022 Apr; 480(4):759-769. PubMed ID: 35089403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.